Skip to main content
UHSUniversal Health Services, Inc.Buy Wait6.2·$144.59-1.25%
Open full analysis

Universal Health Services, Inc. (UHS) Stock Analysis

Buy WaitAI GATE: FLAGGED — 1 riskModerate Confidence

Healthcare · Medical Care Facilities

Wait for pullback to $142.77. Below 200-day MA (death cross); also weak momentum — blocks BUY_NOW at $144.59. Engine's entry $142.77 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Below 200-MA, MA slope -1.0%/30d (confirmed downtrend).

UHS owns and operates 375 inpatient facilities and 168 outpatient facilities in 40 states, D.C., UK, and Puerto Rico, including acute care hospitals and behavioral health centers. Revenue comes from Medicare, Medicaid, and private payers; acute care represents ~57% and... Read more

$144.59+36.3% A.UpsideScore 6.2/10#3 of 27 Medical Care Facilities
QualityF-score8 / 9FCF yield7.34%
IncomeYield0.55%(5y avg 0.51%)Payout3.34%sustainable
Entry $142.77(Support Atr Sticky)Stop $133.22Target $194.19(analyst − 10%)A.R:R 5.2:1Setup A.R:R 7.9:1
Analyst target$215.76+49.2%17 analysts
$194.19our TP
$144.59price
$215.76mean
$310

Wait for pullback to $142.77. Below 200-day MA (death cross); also weak momentum — blocks BUY_NOW at $144.59. Engine's entry $142.77 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Below 200-MA, MA slope -1.0%/30d (confirmed downtrend). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Score 6.2/10, moderate confidence.

Passes 8/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 42d clear, semi cycle peak clear, materials cycle peak clear). Fails on death cross (50MA < 200MA). Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Jul 27, 202642d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
Positive news sentiment (+0.67)
Attractive valuation
Risks
Below 200-MA, MA slope -1.0%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)6.1
P/E (Fwd)5.8
Mkt Cap$8.9B
EV/EBITDA5.3
Profit Mgn8.6%
ROE21.4%
Rev Growth9.6%
Beta1.08
Dividend0.55%
Rating analysts26

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C2.08bearish
IV53%elevated
Max Pain$220+52.2% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 ceiling hit

GatesDeath cross (50MA < 200MA)Momentum 4.9<5.5 (soft — BUY_NOW allowed but watch)Momentum 4.9>=4.5A.R:R 5.2 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 42d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
33 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $140.08Resistance $171.94

Price Targets

$133
$143
$194
A.Upside+34.3%
A.R:R5.2:1
Setup A.R:R (at entry)7.9:1

Position Sizing

ConvictionMedium conviction
Suggested %0.8%
Max %1.7%
RegimeSteady

Risk Alerts

! NEWS_MOD=+2: HOLD_IF_HOLDING → STRONG_BUY_WAIT
! Death cross — 50-day MA below 200-day MA
! News gate: flagged (1 risks, 0 concerns)

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-07-27 (42d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Wait for pullback to $142.77. Below 200-day MA (death cross); also weak momentum — blocks BUY_NOW at $144.59. Engine's entry $142.77 (Support Atr Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Below 200-MA, MA slope -1.0%/30d (confirmed downtrend). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. | News modifier +2 (HOLD_IF_HOLDING → STRONG_BUY_WAIT) Target $194.19 (+34.3%), stop $133.22 (−8.5%), Setup A.R:R 7.9:1. Score 6.2/10, moderate confidence.

What is the UHS stock price target?

Take-profit target: $194.19 (+36.3% upside). Target $194.19 (+34.3%), stop $133.22 (−8.5%), Setup A.R:R 7.9:1. Stop-loss: $133.22.

What are the risks of investing in UHS?

Below 200-MA, MA slope -1.0%/30d (confirmed downtrend).

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 6.1 (forward 5.8). TrendMatrix value score: 9.0/10. Verdict: Buy (Wait for Entry).

What do analysts say about UHS?

26 analysts cover UHS with a consensus score of 3.5/5. Average price target: $216.

What does Universal Health Services, Inc. do?UHS owns and operates 375 inpatient facilities and 168 outpatient facilities in 40 states, D.C., UK, and Puerto Rico,...

UHS owns and operates 375 inpatient facilities and 168 outpatient facilities in 40 states, D.C., UK, and Puerto Rico, including acute care hospitals and behavioral health centers. Revenue comes from Medicare, Medicaid, and private payers; acute care represents ~57% and behavioral health ~43% of net revenues. UK behavioral health generated ~$1.0B in 2025.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · THC (Tenet Healthcare Corporation) · ASTH (Astrana Health Inc.) · ARDT (Ardent Health, Inc.) · CON (Concentra Group Holdings Parent)
Home Stocks UHS

Latest news

Latest News

TMX Newsfile4d agoRISKLegal
MarketWatch54d ago
Yahoo Finance54d ago
Yahoo Finance54d agoEarnings
The Globe and Mail55d agoEarnings
TradingView55d agoEarnings
Yahoo Finance6d ago
Newsline.com7d agoEarnings
Insider Monkey4d agoAnalyst
AD HOC NEWS11d ago
The Globe and Mail51d agoEarnings
AD HOC NEWS57d ago
Newsline.com2d ago
HarianBasis.co8d ago
Yahoo Finance8d ago
Sahm51d agoEarnings
MarketBeat52d ago
Quiver Quantitative49d agoEarnings
TradingView49d ago
WKYC49d agoEarnings
Loading more...